Latest filing published 16 Sept 2026 for Recursion Pharmaceuticals, INC., €16k. Read the official filing
All filings by Ben R. Taylor on record concern Recursion Pharmaceuticals, Inc. The record holds 20 filings, for trades running from 16 December 2024 to 15 September 2026.
Sales make up the whole of the open-market record (1 sale, €76k). Other entries cover 19 share grants.
The latest filing, published on 16 September 2026, reports a share grant of €16k in Recursion Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations